AVANOS MEDICAL UK LIMITED
Get an alert when AVANOS MEDICAL UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-22 (this month)
Last made up 2025-05-08
Watchouts
None on the register
Cash
£7M
-13.6% vs 2023
Net assets
£2M
-52% vs 2023
Employees
19
-5% vs 2023
Profit before tax
£2M
+93.3% vs 2023
Name history
Renamed 1 time since incorporation
- AVANOS MEDICAL UK LIMITED 2019-02-05 → present
- HALYARD HEALTH UK LIMITED 2014-05-21 → 2019-02-05
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £18,480,966 | £18,626,810 | |
| Operating profit | £800,452 | £1,853,054 | |
| Profit before tax | £1,120,756 | £2,166,600 | |
| Net profit | £869,317 | £1,607,985 | |
| Cash | £7,892,911 | £6,819,024 | |
| Total assets less current liabilities | £4,611,156 | £2,214,944 | |
| Net assets | £4,598,197 | £2,206,182 | |
| Equity | £4,598,197 | £2,206,182 | |
| Average employees | 20 | 19 | |
| Wages | £2,572,666 | £2,107,315 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.3% | 9.9% | |
| Net margin | 4.7% | 8.6% | |
| Return on capital employed | 17.4% | 83.7% | |
| Gearing (liabilities / total assets) | 58.0% | 77.6% | |
| Current ratio | 1.72x | 1.29x | |
| Interest cover | 70.39x | 31.80x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are confident that the company has the ability to continue to operate as a going concern for at least 12 months from the date of signing. They acknowledge reliance on group cash pooling and distribution agreement, and have obtained a letter of support from the ultimate parent Avanos Medical Inc. to cover the going concern period.”
Significant events
- “Avanos Medical Inc. entered an agreement to sell its 'Respiratory Health' business to SunMed Group Holdings, LLC, effective 1 October 2023. The UK company acted as a limited risk distributor until 31 October 2024, after which the sale was fully concluded.”
- “On 29 May 2024, the company passed a special resolution to cancel share premium of £488,197 and reduce share capital by £527,399. A dividend of £4,000,000 was settled to the parent company on 31 May 2024.”
- “Subsequent to the year end, the company acquired intangible assets for a cash amount of £2.4m, related to a transfer of assets from one of its distributors.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KRINES, Dieter | Director | 2022-01-24 | Aug 1966 | German |
| VANDEROOST, Nancy Carine C | Director | 2018-04-06 | Nov 1967 | Belgian |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WOODS, Peter | Secretary | 2014-05-21 | 2014-10-16 |
| ALLSOP, James Cantle | Director | 2019-06-10 | 2021-11-21 |
| CASPAR, Thierry Charles-Andre | Director | 2018-04-06 | 2019-06-10 |
| DESCHAMPS, Pierre Gilles Yves | Director | 2014-05-21 | 2018-04-06 |
| DHILLON, Kalbander Singh | Director | 2014-05-21 | 2014-10-06 |
| MCPHERSON, Donna | Director | 2014-05-21 | 2014-10-06 |
| PRICE, Jonathan David | Director | 2014-10-06 | 2015-02-20 |
| VERREYDT, Bart | Director | 2014-10-06 | 2018-04-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Avanos Medical, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 54 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-05-30 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-22 | AA | accounts | Accounts with accounts type full | |
| 2025-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-29 | AA | accounts | Accounts with accounts type full | |
| 2024-05-30 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2024-05-30 | CAP-SS | insolvency | Legacy | |
| 2024-05-30 | RESOLUTIONS | resolution | Resolution | |
| 2024-05-30 | SH20 | capital | Legacy | |
| 2024-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-25 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-10-06 | AA | accounts | Accounts with accounts type full | |
| 2023-06-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-24 | RP05 | address | Default companies house registered office address applied | |
| 2022-12-06 | AA | accounts | Accounts with accounts type full | |
| 2022-05-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-02-09 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-08 | TM01 | officers | Termination director company with name termination date | |
| 2021-09-30 | AA | accounts | Accounts with accounts type full | |
| 2021-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-01-19 | AA | accounts | Accounts with accounts type full | |
| 2020-05-25 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+0.8%
£18,480,966 £18,626,810
-
Cash
-13.6%
£7,892,911 £6,819,024
-
Net assets
-52%
£4,598,197 £2,206,182
-
Employees
-5%
20 19
-
Operating profit
+131.5%
£800,452 £1,853,054
-
Profit before tax
+93.3%
£1,120,756 £2,166,600
-
Wages
-18.1%
£2,572,666 £2,107,315
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers